Showing results (371-380 of 781) with videos related to
Sort By:
Pageof 79
British Journal of Haematology|July 13, 2010
Tanespimycin monotherapy in relapsed multiple myeloma: results of a phase 1 dose-escalation studyPaul G Richardson, Asher A Chanan-Khan, Melissa Alsina, et al.Blood|September 1, 2010
A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myelomaDharminder Chauhan, Ajita V Singh, Monette Aujay, et al.Cancer Letters|February 28, 2002
Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitorsMasaharu Akiyama, Osamu Yamada, Naotoshi Kanda, et al.Nature Reviews. Disease Primers|July 21, 2017
Multiple myelomaShaji K Kumar, Vincent Rajkumar, Robert A Kyle, et al.Future Oncology (London, England)|December 23, 2017
Isatuximab plus pomalidomide/dexamethasone versus pomalidomide/dexamethasone in relapsed/refractory multiple myeloma: ICARIA Phase III study designPaul G Richardson, Michel Attal, Frank Campana, et al.Blood|July 23, 2025
A BCMA-mRNA vaccine is a promising therapeutic for multiple myelomaDebasmita Dutta, Jiye Liu, Kenneth Wen, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 15, 2016
Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone DiseaseHomare Eda, Loredana Santo, Marc N Wein, et al.British Journal of Haematology|December 1, 2010
PR-924, a selective inhibitor of the immunoproteasome subunit LMP-7, blocks multiple myeloma cell growth both in vitro and in vivoAjita V Singh, Madhavi Bandi, Monette A Aujay, et al.Expert Review of Proteomics|November 15, 2018
The power of proteasome inhibition in multiple myelomaThomas A Guerrero-Garcia, Sara Gandolfi, Jacob P Laubach, et al.Blood|February 8, 2022
Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myelomaGeorgina S F Anderson, Jose Ballester-Beltran, George Giotopoulos, et al.Pageof 79